HSTM Stock Analysis: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$28.41
0.13 (0.46%)
▲
5d:
+10.54%
30d:
+12.65%
90d:
+39.26%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 03, 2026
30d
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HSTM trades at premium valuation expecting 7.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: HSTM trades at premium valuation expecting 7.1% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.44
Based on 7.1% avg growth
INTRINSIC VALUE TODAY
$18.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $28.41, which is considered extended relative to its 30-day fair value range of $24.85 to $26.88. From a valuation perspective, the stock is trading at a premium (Forward PE: 32.8) compared to its historical average (26.7). At these levels, the market is pricing in 7.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSTM is in a strong uptrend. The price is approaching resistance at $28.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HSTM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $32.00 (+12.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HSTM is in a strong uptrend. The price is approaching resistance at $28.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HSTM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $32.00 (+12.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$24.85 -
$26.88
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
53.8%
All Signals
- BEARISH: Price extended above range (+5.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($32.00)
- NEUTRAL: Trading at premium valuation - market expects 7.1% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$24.85 -
$26.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$25.28
Resistance Level
$28.79
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
32.84
Wall Street Target
$32.00
(+12.6%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
42.9%
Profit Margin
6.4%
Valuation Premium vs History
+7.1% premium
PE vs Historical
32.8 vs 26.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.1%
(market-implied from PE analysis)
1-Year Target
$30.43
(+7%)
2-Year Target
$32.59
(+15%)
3-Year Target
$34.90
(+23%)
3-Yr Target (if PE normalizes)
(PE: 33→27)
PE COMPRESSION
$28.37
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.8, Growth: 10.2%)
$38.01
(+34%)
Base:
(SPY PE: 21.8, Growth: 10.2%)
$25.21
(-11%)
Bear:
(PE: 18.5, Growth: 10.2%)
$21.43
(-25%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (42x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Trailing PE: 42.21 | Current EPS (TTM): $0.67
Bull Case
$40.16
(+41%)
Analyst growth 29.1%, PE expands to 46.4
Base Case
$36.51
(+29%)
Market implied 29.1%, PE stable at 42.2
Bear Case
$19.23
(-32%)
Severe decline -20.0%, PE contracts to 35.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 5:59 PM ET
Data refreshes hourly during market hours. Next update: 6:59 PM
Data refreshes hourly during market hours. Next update: 6:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |
